Loading…
Based on limited metadata, this FDA Warning Letter issued to www.outoftheboxremedies.com on June 10, 2020 concerns unapproved or misbranded drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined, though they likely involve regulatory non-compliance in product claims, approvals, or labeling. The warning falls under FDA's drug product oversight authority, though the specific issuing office is not identified in the available metadata.